#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Acts as a Tumor Suppressor in a Murine Retinoblastoma Model by Facilitating Tumor Cell Death


CDH11 gene copy number and expression are frequently lost in human retinoblastomas and in retinoblastomas arising in TAg-RB mice. To determine the effect of Cdh11 loss in tumorigenesis, we crossed Cdh11 null mice with TAg-RB mice. Loss of Cdh11 had no gross morphological effect on the developing retina of Cdh11 knockout mice, but led to larger retinal volumes in mice crossed with TAg-RB mice (p = 0.01). Mice null for Cdh11 presented with fewer TAg-positive cells at postnatal day 8 (PND8) (p = 0.01) and had fewer multifocal tumors at PND28 (p = 0.016), compared to mice with normal Cdh11 alleles. However, tumor growth was faster in Cdh11-null mice between PND8 and PND84 (p = 0.003). In tumors of Cdh11-null mice, cell death was decreased 5- to 10-fold (p<0.03 for all markers), while proliferation in vivo remained unaffected (p = 0.121). Activated caspase-3 was significantly decreased and β-catenin expression increased in Cdh11 knockdown experiments in vitro. These data suggest that Cdh11 displays tumor suppressor properties in vivo and in vitro in murine retinoblastoma through promotion of cell death.


Vyšlo v časopise: Acts as a Tumor Suppressor in a Murine Retinoblastoma Model by Facilitating Tumor Cell Death. PLoS Genet 6(4): e32767. doi:10.1371/journal.pgen.1000923
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000923

Souhrn

CDH11 gene copy number and expression are frequently lost in human retinoblastomas and in retinoblastomas arising in TAg-RB mice. To determine the effect of Cdh11 loss in tumorigenesis, we crossed Cdh11 null mice with TAg-RB mice. Loss of Cdh11 had no gross morphological effect on the developing retina of Cdh11 knockout mice, but led to larger retinal volumes in mice crossed with TAg-RB mice (p = 0.01). Mice null for Cdh11 presented with fewer TAg-positive cells at postnatal day 8 (PND8) (p = 0.01) and had fewer multifocal tumors at PND28 (p = 0.016), compared to mice with normal Cdh11 alleles. However, tumor growth was faster in Cdh11-null mice between PND8 and PND84 (p = 0.003). In tumors of Cdh11-null mice, cell death was decreased 5- to 10-fold (p<0.03 for all markers), while proliferation in vivo remained unaffected (p = 0.121). Activated caspase-3 was significantly decreased and β-catenin expression increased in Cdh11 knockdown experiments in vitro. These data suggest that Cdh11 displays tumor suppressor properties in vivo and in vitro in murine retinoblastoma through promotion of cell death.


Zdroje

1. GallieBL

CampbellC

DevlinH

DuckettA

SquireJA

1999 Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 59 1731s 1735s

2. DimarasH

CoburnB

PajovicS

GallieBL

2006 Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma. Mol Carcinog 45 333 343

3. DimarasH

KhetanV

HallidayW

OrlicM

PrigodaNL

2008 Loss of RB1 induces non-proliferative retinoma; increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet

4. SquireJ

GallieBL

PhillipsRA

1985 A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 70 291 301

5. ChenD

GallieBL

SquireJA

2001 Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 129 57 63

6. HerzogS

LohmannDR

BuitingK

SchulerA

HorsthemkeB

2001 Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization. Hum Genet 108 98 104

7. LillingtonDM

KingstonJE

CoenPG

PriceE

HungerfordJ

2003 Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer 36 121 128

8. MairalA

PinglierE

GilbertE

PeterM

ValidireP

2000 Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer 28 370 379

9. van der WalJE

HermsenMA

GilleHJ

Schouten-Van MeeterenNY

MollAC

2003 Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group. J Clin Pathol 56 26 30

10. ZielinskiB

GratiasS

ToedtG

MendrzykF

StangeDE

2005 Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 43 294 301

11. CorsonTW

HuangA

TsaoMS

GallieBL

2005 KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 24 4741 4753

12. OrlicM

SpencerCE

WangL

GallieBL

2006 Expression analysis of 6p22 genomic gain in retinoblastoma. Genes Chromosomes Cancer 45 72 82

13. MarchongMN

ChenD

CorsonTW

LeeC

HarmandayanM

2004 Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res 2 495 503

14. GrasemannC

GratiasS

StephanH

SchulerA

SchrammA

2005 Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene 24 6441 6449

15. BowlesE

CorsonTW

BayaniJ

SquireJA

WongN

2007 Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosomes Cancer 46 118 129

16. WindleJJ

AlbertDM

O'BrienJM

MarcusDM

DistecheCM

1990 Retinoblastoma in transgenic mice. Nature 343 665 669

17. GratiasS

SchulerA

HitpassLK

StephanH

RiederH

2005 Genomic gains on chromosome 1q in retinoblastoma: consequences on gene expression and association with clinical manifestation. Int J Cancer 116 555 563

18. LaurieN

MohanA

McEvoyJ

ReedD

ZhangJ

2009 Changes in Retinoblastoma Cell Adhesion Associated with Optic Nerve Invasion. Mol Cell Biol

19. DimarasH

GallieBL

2008 The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development. Int J Cancer 122 2023 2029

20. AlbertDM

KumarA

StrugnellSA

DarjatmokoSR

LokkenJM

2004 Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models. Arch Ophthalmol 122 1357 1362

21. DawsonDG

GleiserJ

ZimbricML

DarjatmokoSR

LindstromMJ

2003 Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. Ophthalmology 110 835 839

22. Escalona-BenzE

JockovichME

MurrayTG

HaydenB

HernandezE

2005 Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma. Invest Ophthalmol Vis Sci 46 8 11

23. MurrayTG

CicciarelliN

O'BrienJM

HernandezE

MuellerRL

1997 Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch Ophthalmol 115 1286 1290

24. TongCT

HowardSA

ShahHR

Van QuillKR

LinET

2005 Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma. Br J Ophthalmol 89 1217 1220

25. Van QuillKR

DioguardiPK

TongCT

GilbertJA

AabergTMJr

2005 Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology 112 1151 1158

26. ChenD

Livne-barI

VanderluitJL

SlackRS

AgochiyaM

2004 Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5 539 551

27. MacPhersonD

ConkriteK

TamM

MukaiS

MuD

2007 Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification. Embo J 26 784 794

28. MacPhersonD

SageJ

KimT

HoD

McLaughlinME

2004 Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 18 1681 1694

29. Robanus-MaandagE

DekkerM

van der ValkM

CarrozzaML

JeannyJC

1998 p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12 1599 1609

30. ZhangJ

SchweersB

DyerMA

2004 The first knockout mouse model of retinoblastoma. Cell Cycle 3 952 959

31. HoffmannI

BallingR

1995 Cloning and expression analysis of a novel mesodermally expressed cadherin. Dev Biol 169 337 346

32. DimarasH

MarchongMN

GallieBL

2009 Quantitative analysis of tumor size in a murine model of retinoblastoma. Ophthalmic Genet 30 84 90

33. HorikawaK

RadiceG

TakeichiM

ChisakaO

1999 Adhesive subdivisions intrinsic to the epithelial somites. Dev Biol 215 182 189

34. KawaguchiJ

AzumaY

HoshiK

KiiI

TakeshitaS

2001 Targeted disruption of cadherin-11 leads to a reduction in bone density in calvaria and long bone metaphyses. J Bone Miner Res 16 1265 1271

35. MarchongM

2007 Identification of CDH11 as a Candidate Tumor Suppressor in Retinoblastoma and Characterization of its role in Retina and Retinoblastoma. Toronto University of Toronto

36. AberleH

SchwartzH

KemlerR

1996 Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 61 514 523

37. WheelockMJ

JohnsonKR

2003 Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19 207 235

38. KinzlerKW

VogelsteinB

1996 Lessons from hereditary colorectal cancer. Cell 87 159 170

39. MorinPJ

SparksAB

KorinekV

BarkerN

CleversH

1997 Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 1787 1790

40. AlmeidaM

HanL

BellidoT

ManolagasSC

KousteniS

2005 Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280 41342 41351

41. CoxRT

KirkpatrickC

PeiferM

1996 Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis. J Cell Biol 134 133 148

42. FagottoF

FunayamaN

GluckU

GumbinerBM

1996 Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus. J Cell Biol 132 1105 1114

43. HeasmanJ

CrawfordA

GoldstoneK

Garner-HamrickP

GumbinerB

1994 Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 79 791 803

44. KanaiY

UshijimaS

HuiAM

OchiaiA

TsudaH

1997 The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71 355 359

45. Faulkner-JonesBE

GodinhoLN

ReeseBE

PasquiniGF

RuefliA

1999 Cloning and expression of mouse Cadherin-7, a type-II cadherin isolated from the developing eye. Mol Cell Neurosci 14 1 16

46. HonjoM

TaniharaH

SuzukiS

TanakaT

HondaY

2000 Differential expression of cadherin adhesion receptors in neural retina of the postnatal mouse. Invest Ophthalmol Vis Sci 41 546 551

47. HojoM

OhtsukaT

HashimotoN

GradwohlG

GuillemotF

2000 Glial cell fate specification modulated by the bHLH gene Hes5 in mouse retina. Development 127 2515 2522

48. EisenfeldAJ

Bunt-MilamAH

SaariJC

1985 Localization of retinoid-binding proteins in developing rat retina. Exp Eye Res 41 299 304

49. LinserP

MosconaAA

1981 Carbonic anhydrase C in the neural retina: transition from generalized to glia-specific cell localization during embryonic development. Proc Natl Acad Sci 78 7190 7194

50. InoueA

ObataK

AkagawaK

1992 Cloning and sequence analysis of cDNA for a neuronal cell membrane antigen, HPC-1. J Biol Chem 267 10613 10619

51. VaughanDK

LasaterEM

1990 Glial and neuronal markers in bass retinal horizontal and Muller cells. Brain Res 537 131 140

52. FedtsovaNG

TurnerEE

1995 Brn-3.0 expression identifies early post-mitotic CNS neurons and sensory neural precursors. Mech Dev 53 291 304

53. LiuIS

ChenJD

PloderL

VidgenD

van der KooyD

1994 Developmental expression of a novel murine homeobox gene (Chx10): evidence for roles in determination of the neuroretina and inner nuclear layer. Neuron 13 377 393

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2010 Číslo 4
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#